A Agilent Technologies Inc.

Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29

SANTA CLARA, Calif.--(BUSINESS WIRE)--

Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT.

To join the listen-only conference call webcast, click the link on the of Agilent’s investor relations website. A recording of the call will also be available on the website for 90 days.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, subscribe to the . Follow Agilent on and .

EN
02/05/2024

Underlying

AAgilent Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

 PRESS RELEASE
Free
A Agilent Technol...

Agilent Presents Solutions Innovation Research Awards to Cornell and I...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced two Solutions Innovation Research Awards (SIRA) presented to Professors and . These separate awards recognize their outstanding contributions to advanced materials research. Electrocatalysis plays a pivotal role in advancing clean energy systems. Enhancing the efficiency of chemical reactions at electrode surfaces can accelerate the transition to sustainable energy sources. High-entropy nanoparticles—materials that incorporate many different types of atoms into one lattice—offer a fresh perspective in electrocatalysis. Their ...

19h / 20m 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT. To join the listen-only conference call webcast, click the link on the of Agilent’s investor relations website. A recording of the call will also be available on the website for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory tec...

May 2, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Padraig McDonnell Assumes Agilent CEO Role

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO . McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. 31. This press release features multimedia. View the full release here: Padraig McDonnell (Photo: Business Wire) “It’s an incredible honor to serve as CEO of this great company that impacts the world by advancing the quality of life,” McDonnell said. ...

May 1, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cy...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains—from basic research to drug discovery and therapy development. The NovoCyte Opteon represents a significant leap forward in flow cytometry technology, with configurations ranging from three to five lasers and support for up to 73 high-quality detectors. It meets researchers’ needs for sophisticated, large-...

May 1, 2024 1 EN
 PRESS RELEASE
Free
A Agilent Technol...

Agilent Names Simon May to Lead Diagnostics and Genomics Group

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6. “We are excited to welcome Simon May to the Agilent team,” said Padraig McDonnell, COO and CEO-elect. “Simon’s deep technical knowledge, his broad range of experience, and his career-long focus on strategy, continuous improvement and operational excellence are critical additions to...

April 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch